Using arterial-venous oxygen difference to guide red blood cell transfusion strategy

Area of Science:

• Critical Care Medicine
• Hematology
• Physiology

Background:

• Current guidelines recommend restrictive red blood cell (RBC) transfusion strategies for critically ill patients based on hemoglobin (Hb) levels.
• The arterial-venous oxygen difference (A-V O2diff), reflecting oxygen delivery and consumption, may offer a more personalized transfusion approach.

Purpose of the Study:

• To investigate if A-V O2diff can identify critically ill patients who benefit from RBC transfusion.
• To compare mortality rates between patients transfused based on A-V O2diff versus standard Hb-based guidelines.

Main Methods:

• Prospective observational study of 177 non-bleeding adult ICU patients with Hb 7.0-10.0 g/dL.
• Measured A-V O2diff, ScvO2, and O2ER at the time Hb was within the target range.
• Classified transfusion strategy as 'appropriate' or 'inappropriate' based on a median A-V O2diff threshold of 3.7 mL; primary outcome was 90-day mortality.

Main Results:

• An 'appropriate' transfusion strategy was associated with significantly lower 90-day mortality (24% vs. 44%, p=0.004).
• Appropriate strategy independently reduced mortality (HR 0.51, p=0.01) and showed a trend towards less acute kidney injury.
• A-V O2diff moderately predicted mortality in both transfused and non-transfused groups, with optimal cutoffs around 3.5-3.6 mL.

Conclusions:

• In anemic, non-bleeding critically ill patients, RBC transfusion guided by higher A-V O2diff may reduce 90-day mortality and morbidity.
• A-V O2diff serves as a valuable physiological marker for personalized transfusion decisions in critical care.